These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12411296)

  • 1. Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia.
    Molina-Arcas M; Bellosillo B; Casado FJ; Montserrat E; Gil J; Colomer D; Pastor-Anglada M
    Blood; 2003 Mar; 101(6):2328-34. PubMed ID: 12411296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equilibrative nucleoside transporter-2 (hENT2) protein expression correlates with ex vivo sensitivity to fludarabine in chronic lymphocytic leukemia (CLL) cells.
    Molina-Arcas M; Marcé S; Villamor N; Huber-Ruano I; Casado FJ; Bellosillo B; Montserrat E; Gil J; Colomer D; Pastor-Anglada M
    Leukemia; 2005 Jan; 19(1):64-8. PubMed ID: 15510196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations.
    Mackey JR; Galmarini CM; Graham KA; Joy AA; Delmer A; Dabbagh L; Glubrecht D; Jewell LD; Lai R; Lang T; Hanson J; Young JD; Merle-Béral H; Binet JL; Cass CE; Dumontet C
    Blood; 2005 Jan; 105(2):767-74. PubMed ID: 15454483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells.
    López-Guerra M; Trigueros-Motos L; Molina-Arcas M; Villamor N; Casado FJ; Montserrat E; Campo E; Colomer D; Pastor-Anglada M
    Haematologica; 2008 Dec; 93(12):1843-51. PubMed ID: 18945750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of fludarabine sensitivity by all-trans-retinoic acid in chronic lymphocytic leukemia cells.
    Fernández-Calotti PX; Lopez-Guerra M; Colomer D; Pastor-Anglada M
    Haematologica; 2012 Jun; 97(6):943-51. PubMed ID: 22180426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of nucleoside and nucleobase transporter gene expression with antimetabolite drug cytotoxicity.
    Lu X; Gong S; Monks A; Zaharevitz D; Moscow JA
    J Exp Ther Oncol; 2002; 2(4):200-12. PubMed ID: 12416024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research advance on fludarabine resistance mechanisms in chronic lymphocytic leukemia cells].
    Yao L; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):821-4. PubMed ID: 20561458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia.
    Moussay E; Palissot V; Vallar L; Poirel HA; Wenner T; El Khoury V; Aouali N; Van Moer K; Leners B; Bernardin F; Muller A; Cornillet-Lefebvre P; Delmer A; Duhem C; Ries F; van Dyck E; Berchem G
    Mol Cancer; 2010 May; 9():115. PubMed ID: 20487546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia.
    Fernández Calotti P; Galmarini CM; Cañones C; Gamberale R; Saénz D; Avalos JS; Chianelli M; Rosenstein R; Giordano M
    Biochem Pharmacol; 2008 Feb; 75(4):857-65. PubMed ID: 18078872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemia.
    Tsang RY; Santos C; Ghosh S; Dabbagh L; King K; Young J; Cass CE; Mackey JR; Lai R
    Mod Pathol; 2008 Nov; 21(11):1387-93. PubMed ID: 18604194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabine.
    Huang P; Sandoval A; Van Den Neste E; Keating MJ; Plunkett W
    Leukemia; 2000 Aug; 14(8):1405-13. PubMed ID: 10942236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bryostatin 1-induced modulation of nucleoside transporters and 2-chlorodeoxyadenosine influx in WSU-CLL cells.
    Beck FW; Al-Katib AM; Ahmad I; Wall NR; Liu KZ; Mantsch HH; Mohammad RM
    Int J Mol Med; 2000 Apr; 5(4):341-7. PubMed ID: 10719048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine.
    de la Fuente MT; Casanova B; Moyano JV; Garcia-Gila M; Sanz L; Garcia-Marco J; Silva A; Garcia-Pardo A
    J Leukoc Biol; 2002 Mar; 71(3):495-502. PubMed ID: 11867687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia.
    Ferracin M; Zagatti B; Rizzotto L; Cavazzini F; Veronese A; Ciccone M; Saccenti E; Lupini L; Grilli A; De Angeli C; Negrini M; Cuneo A
    Mol Cancer; 2010 May; 9():123. PubMed ID: 20504344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
    J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
    Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
    Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia.
    Olsson A; Norberg M; Okvist A; Derkow K; Choudhury A; Tobin G; Celsing F; Osterborg A; Rosenquist R; Jondal M; Osorio LM
    Br J Cancer; 2007 Sep; 97(6):769-77. PubMed ID: 17726463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human concentrative nucleoside transporter 3 is a determinant of fludarabine transportability and cytotoxicity in human renal proximal tubule cell cultures.
    Elwi AN; Damaraju VL; Kuzma ML; Baldwin SA; Young JD; Sawyer MB; Cass CE
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):289-301. PubMed ID: 18500522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes.
    Adams DJ; Levesque MC; Weinberg JB; Smith KL; Flowers JL; Moore J; Colvin OM; Silber R
    Leukemia; 2001 Dec; 15(12):1852-9. PubMed ID: 11753605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine.
    Menzel T; Rahman Z; Calleja E; White K; Wilson EL; Wieder R; Gabrilove J
    Blood; 1996 Feb; 87(3):1056-63. PubMed ID: 8562930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.